REELIN and schizophrenia: a disease at the interface of the genome and the epigenome - PubMed (original) (raw)
Review
REELIN and schizophrenia: a disease at the interface of the genome and the epigenome
E Costa et al. Mol Interv. 2002 Feb.
Abstract
The downregulation of the Reelin gene (RELN) that occurs in schizophrenic brains, which are characterized by pyramidal neurons with shortened dendrites and by reduced expression densities of dendritic spines, may well result from hypermethylation of the RELN promoter. In the adult mammalian brain, gamma-aminoburytic acid-secreting (GABAergic) interneurons release RELN into the extracellular matrix, where it binds with high affinity to the integrin receptors present at dendritic spine postsynaptic densities and likely plays a role, elaborated in this article, in synaptic plasticity. In heterozygous reeler mice, which are haploinsufficient in RELN, inhibitors of histone deacetylase increase DNA demethylase activity and restore RELN expression. Such inhibitors could thus be of therapeutic value in mitigating vulnerability to schizophrenia among high-risk individuals.
Similar articles
- Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability.
Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C. Costa E, et al. Neurobiol Dis. 2001 Oct;8(5):723-42. doi: 10.1006/nbdi.2001.0436. Neurobiol Dis. 2001. PMID: 11592844 Review. - Reelin glycoprotein: structure, biology and roles in health and disease.
Fatemi SH. Fatemi SH. Mol Psychiatry. 2005 Mar;10(3):251-7. doi: 10.1038/sj.mp.4001613. Mol Psychiatry. 2005. PMID: 15583703 Review. - Epigenetic silencing of RELN in gastric cancer.
Dohi O, Takada H, Wakabayashi N, Yasui K, Sakakura C, Mitsufuji S, Naito Y, Taniwaki M, Yoshikawa T. Dohi O, et al. Int J Oncol. 2010 Jan;36(1):85-92. Int J Oncol. 2010. PMID: 19956836 - Methylation status of the reelin promoter region in the brain of schizophrenic patients.
Tochigi M, Iwamoto K, Bundo M, Komori A, Sasaki T, Kato N, Kato T. Tochigi M, et al. Biol Psychiatry. 2008 Mar 1;63(5):530-3. doi: 10.1016/j.biopsych.2007.07.003. Epub 2007 Sep 17. Biol Psychiatry. 2008. PMID: 17870056 - Reelin-deficient mice show impaired neurogenesis and increased stroke size.
Won SJ, Kim SH, Xie L, Wang Y, Mao XO, Jin K, Greenberg DA. Won SJ, et al. Exp Neurol. 2006 Mar;198(1):250-9. doi: 10.1016/j.expneurol.2005.12.008. Epub 2006 Jan 24. Exp Neurol. 2006. PMID: 16438965
Cited by
- Fate of cajal-retzius neurons in the postnatal mouse neocortex.
Chowdhury TG, Jimenez JC, Bomar JM, Cruz-Martin A, Cantle JP, Portera-Cailliau C. Chowdhury TG, et al. Front Neuroanat. 2010 Mar 3;4:10. doi: 10.3389/neuro.05.010.2010. eCollection 2010. Front Neuroanat. 2010. PMID: 20339484 Free PMC article. - Epigenetic mechanisms in schizophrenia.
Roth TL, Lubin FD, Sodhi M, Kleinman JE. Roth TL, et al. Biochim Biophys Acta. 2009 Sep;1790(9):869-77. doi: 10.1016/j.bbagen.2009.06.009. Epub 2009 Jun 25. Biochim Biophys Acta. 2009. PMID: 19559755 Free PMC article. Review. - DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.
Dong E, Ruzicka WB, Grayson DR, Guidotti A. Dong E, et al. Schizophr Res. 2015 Sep;167(1-3):35-41. doi: 10.1016/j.schres.2014.10.030. Epub 2014 Dec 2. Schizophr Res. 2015. PMID: 25476119 Free PMC article. - On the epigenetic regulation of the human reelin promoter.
Chen Y, Sharma RP, Costa RH, Costa E, Grayson DR. Chen Y, et al. Nucleic Acids Res. 2002 Jul 1;30(13):2930-9. doi: 10.1093/nar/gkf401. Nucleic Acids Res. 2002. PMID: 12087179 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical